IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Deerfield Management Company, L.P.

Q2 2025 Holdings

Filed 2025-08-14 | 124 holdings | $5.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Larimar Therapeutics Inc(LRMR)COM517125100$61.4M21,231,9741.1%
Catalyst Pharmaceuticals Inc(CPRX)COM14888U101$62.5M2,879,4761.1%
Merck & Co Inc(MRK)COM58933Y105$67.9M857,7241.2%
Insmed Inc(INSM)COM PAR $.01457669307$70.5M700,7001.3%
Vera Therapeutics Inc(VERA)CL A92337R101$78.9M3,348,1171.4%
Ideaya Biosciences Inc(IDYA)COM45166A102$82.3M3,915,3111.5%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$92.6M5,115,9531.7%
Adapthealth Corp(AHCO)COMMON STOCK00653Q102$93.4M9,904,8951.7%
Pfizer Inc(PFE)COM717081103$104.4M4,306,2641.9%
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$105.1M2,962,3381.9%
Brookdale SR Living Inc(BKD)COM112463104$106.9M15,362,2641.9%
Mirum Pharmaceuticals IncNOTE 4.000% 5/0604749AB7$124.2M$70,000,0002.3%
Revolution Medicines Inc(RVMD)COM76155X100$124.5M3,384,0722.3%
Alnylam Pharmaceuticals IncNOTE 1.000% 9/102043QAB3$143.2M$110,000,0002.6%
Neurocrine Biosciences Inc(NBIX)COM64125C109$146.8M1,167,8022.7%
United Therapeutics Corp del(UTHR)COM91307C102$155.3M540,6262.8%
Indivior PLC(INDV)ORDG4766E116$155.8M10,567,1602.8%
ARS Pharmaceuticals Inc(SPRY)COM82835W108$169.7M9,724,5083.1%
Integra Lifesciences Hldgs CNOTE 0.500% 8/1457985AM1$172.9M$174,364,0003.1%
Centene Corp del(CNC)COM15135B101$172.9M3,185,3703.1%
Merus N VCOMN5749R100$178.0M3,384,6283.2%
Viatris Inc(VTRS)COM92556V106$214.5M24,023,9073.9%
Oscar Health Inc(OSCR)CL A687793109$249.8M11,649,5914.5%
Nuvalent Inc(NUVL)COM670703107$1.4B17,991,02424.9%
PreviousPage 3 of 3